Sequoia
Senior member
- Joined
- Sep 19, 2010
- Messages
- 841
- Reason
- PALS
- Diagnosis
- 08/2010
- Country
- US
- State
- Washington
- City
- Seattle
Andrew Gengos, Neuraltus CEO, along with a leader (Tom Murphy) and member (Michael) of ALSTUN...ALS Treat Us Now, spent 3 days this week on Capital Hill, speaking mainly with key legislative leaders.
Andrew Gengos had a very consistent and strong message at each session paraphrased as follows:
When the NP001 results are tabulated and formally made public sometime later in 2012 – if the study shows efficacy and safety – Neuraltus plans to ask the FDA for a contingent approval of NP001 immediately and will ask to conduct the Phase III study concurrently with the drugs approval. He asked that if the Phase II results are positive – could he come back to the Congress and get their support for his likely battle with the FDA.
~~To learn more about the 'Hill Summary' and to support ( we need everyone) this vital PALS initiative send ALS TreatUsNow you email address.
Send a private message to me with your email address.
thanks
Andrew Gengos had a very consistent and strong message at each session paraphrased as follows:
When the NP001 results are tabulated and formally made public sometime later in 2012 – if the study shows efficacy and safety – Neuraltus plans to ask the FDA for a contingent approval of NP001 immediately and will ask to conduct the Phase III study concurrently with the drugs approval. He asked that if the Phase II results are positive – could he come back to the Congress and get their support for his likely battle with the FDA.
~~To learn more about the 'Hill Summary' and to support ( we need everyone) this vital PALS initiative send ALS TreatUsNow you email address.
Send a private message to me with your email address.
thanks